Literature DB >> 6477925

Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells.

B S Glisson, S E Smallwood, W E Ross.   

Abstract

Based on the observation that VP-16-induced DNA damage can be demonstrated in isolated nuclei but not in purified DNA, and that this effect is temperature-dependent, it is postulated that the mechanism of action of VP-16 involves an essential intranuclear event, perhaps enzyme-mediated, which is a prerequisite for the cleavage of DNA. Using alkaline elution to assay single-strand breaks in isolated L1210 nuclei, we have further characterized conditions influencing this putative intranuclear reaction. We have found drug activity to be dependent on magnesium and pH and to be stimulated by low concentrations of ATP (0.05-1 mM), an effect which was not observed with a nonhydrolyzable analog of ATP. Heat-labile activity in a nuclear non-histone protein extract was critical to VP-16-mediated DNA damage. This new evidence lends further credence to the hypothesis that activity of an intranuclear enzyme, possessing characteristics consistent with a type II DNA topoisomerase, is a prerequisite for the cleavage of DNA by VP-16.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6477925     DOI: 10.1016/0167-4781(84)90080-0

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  7 in total

1.  Topoisomerase-specific drug sensitivity in relation to cell cycle progression.

Authors:  K C Chow; W E Ross
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

Review 2.  Etoposide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in combination chemotherapy of cancer.

Authors:  J M Henwood; R N Brogden
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

Review 3.  Etoposide and teniposide. Bioanalysis, metabolism and clinical pharmacokinetics.

Authors:  J J Holthuis
Journal:  Pharm Weekbl Sci       Date:  1988-06-17

Review 4.  DNA topoisomerase II as a target of antineoplastic drug therapy.

Authors:  L A Zwelling
Journal:  Cancer Metastasis Rev       Date:  1985       Impact factor: 9.264

5.  Structure-activity relationships of VP-16 analogues.

Authors:  B H Long; A M Casazza
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

6.  Role of the semi-quinone free radical of the anti-tumour agent etoposide (VP-16-213) in the inactivation of single- and double-stranded phi X174 DNA.

Authors:  D R Mans; J Retèl; J M van Maanen; M V Lafleur; M A van Schaik; H M Pinedo; J Lankelma
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

7.  Altered stability of etoposide-induced topoisomerase II-DNA complexes in resistant human leukaemia K562 cells.

Authors:  M K Ritke; D Roberts; W P Allan; J Raymond; V V Bergoltz; J C Yalowich
Journal:  Br J Cancer       Date:  1994-04       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.